Astute Medical Raises Series A Venture Funding
Friday, May 2, 2008 5:31:00 AM PDT | VentureDeal Staff
SAN DIEGO, CA -- Medical device company Astute Medical announced that it has secured $6.25 million in its first round of institutional venture capital funding.

Astute is creating technology that identifies protein biomarkers of severe acute disease in communities and hospitals that require rapid diagnosis and risk assessment.

De Novo Ventures led the round, which included other undisclosed investors.  The company said it would use the funding proceeds to continue its research and development efforts to fund high potential diagnostic candidates.